贝伐单抗玻璃体内注射后并发症的研究现状

Chinese Ophthalmic Research Pub Date : 2010-06-10 DOI:10.3969/J.ISSN.1003-0808.2010.06.025

刘晓娟

{"title":"贝伐单抗玻璃体内注射后并发症的研究现状","authors":"刘晓娟","doi":"10.3969/J.ISSN.1003-0808.2010.06.025","DOIUrl":null,"url":null,"abstract":"玻璃体腔注射bevacizumab治疗多种新生血管性眼病的短期疗效较好,但随着对其研究的不断深入,由玻璃体腔注射的操作过程以及bevacizumab毒性作用等原因引起的一些眼部及全身并发症已逐渐成为临床中不可忽视的问题.就玻璃体腔注射bevacizumab临床应用中出现的并发症,如眼内炎、非感染性眼内炎症反应、一过性眼压升高、结膜下出血、球结膜水肿、视网膜色素上皮(RPE)撕裂、视网膜色素上皮脱离(RPED)、血栓性疾病及子宫不规则出血等进行综述。","PeriodicalId":186994,"journal":{"name":"Chinese Ophthalmic Research","volume":"19 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"2010-06-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Current research incomplications after intravitreal injection of bevacizumab\",\"authors\":\"刘晓娟\",\"doi\":\"10.3969/J.ISSN.1003-0808.2010.06.025\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"玻璃体腔注射bevacizumab治疗多种新生血管性眼病的短期疗效较好,但随着对其研究的不断深入,由玻璃体腔注射的操作过程以及bevacizumab毒性作用等原因引起的一些眼部及全身并发症已逐渐成为临床中不可忽视的问题.就玻璃体腔注射bevacizumab临床应用中出现的并发症,如眼内炎、非感染性眼内炎症反应、一过性眼压升高、结膜下出血、球结膜水肿、视网膜色素上皮(RPE)撕裂、视网膜色素上皮脱离(RPED)、血栓性疾病及子宫不规则出血等进行综述。\",\"PeriodicalId\":186994,\"journal\":{\"name\":\"Chinese Ophthalmic Research\",\"volume\":\"19 1\",\"pages\":\"0\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2010-06-10\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Chinese Ophthalmic Research\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.3969/J.ISSN.1003-0808.2010.06.025\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Chinese Ophthalmic Research","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.3969/J.ISSN.1003-0808.2010.06.025","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}

引用次数: 0

摘要

玻璃体腔注射bevacizumab治疗多种新生血管性眼病的短期疗效较好,但随着对其研究的不断深入,由玻璃体腔注射的操作过程以及bevacizumab毒性作用等原因引起的一些眼部及全身并发症已逐渐成为临床中不可忽视的问题.就玻璃体腔注射bevacizumab临床应用中出现的并发症,如眼内炎、非感染性眼内炎症反应、一过性眼压升高、结膜下出血、球结膜水肿、视网膜色素上皮(RPE)撕裂、视网膜色素上皮脱离(RPED)、血栓性疾病及子宫不规则出血等进行综述。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

查看原文本刊更多论文

Current research incomplications after intravitreal injection of bevacizumab

求助全文

通过发布文献求助，成功后即可免费获取论文全文。去求助

来源期刊

Chinese Ophthalmic Research

自引率

0.00%

发文量